Recipharm to acquire Kemwell


Swedish pharmaceutical contract development and manufacturing organization (CDMO) Recipharm has signed two separate agreements to acquire Kemwell’s pharmaceutical CDMO businesses.

Laboratory_testingKemwell has integrated facilities in India, Sweden and the US and a portfolio of services for sterile and non-sterile products from preformulation to commercial supply worldwide. It offers expertise in inhaled, nasal, oral, parenteral and topical dosage forms.

You must be a subscriber to read this content, or you can register for free to enjoy the current issue.